US Stem Cell (USRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2019 | 12-2018 | 09-2018 | 06-2018 | 03-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -673 | -2,160 | -1,715 | -1,384 | -139 |
| Depreciation Amortization | 82 | 403 | 320 | 236 | 122 |
| Accounts receivable | -68 | -37 | -22 | 1 | -42 |
| Accounts payable and accrued liabilities | 124 | 426 | 333 | 205 | 188 |
| Other Working Capital | 95 | 637 | 732 | 1,335 | 485 |
| Other Operating Activity | 100 | 1,333 | 929 | 276 | 75 |
| Operating Cash Flow | $-340 | $603 | $577 | $668 | $689 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | N/A | N/A | 214 | 109 | 45 |
| Sale Of Investment | 81 | 312 | N/A | N/A | N/A |
| Investing Cash Flow | $81 | $312 | $214 | $109 | $45 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 90 | 350 | 226 | 100 | N/A |
| Debt Issued | N/A | N/A | N/A | 126 | 48 |
| Debt Repayment | N/A | N/A | -543 | -469 | -259 |
| Common Stock Issued | N/A | 368 | 368 | 368 | 368 |
| Other Financing Activity | -438 | -1,262 | -381 | -219 | -160 |
| Financing Cash Flow | $-348 | $-544 | $-330 | $-94 | $-2 |
| Beginning Cash Position | 1,357 | 987 | 987 | 987 | 987 |
| End Cash Position | 749 | 1,357 | 1,448 | 1,670 | 1,718 |
| Net Cash Flow | $-608 | $370 | $461 | $683 | $731 |
| Free Cash Flow | |||||
| Operating Cash Flow | -340 | 603 | 577 | 668 | 689 |
| Free Cash Flow | -340 | 603 | 577 | 668 | 689 |